Microarray analysis in Alzheimer's disease and normal aging

IUBMB Life

Volumn 56, Issue 6, 2004, Pages 349-354

  Ricciarelli, Roberta ^a   D'Abramo, Cristina ^a   Massone, Sara ^a   Marinari, Umberto M ^a   Pronzato, Maria A ^a   Tabaton, Massimo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Aging; Alzheimer's disease; Beta amyloid; Interferon induced protein 3; Microarray

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; INTERFERON; INTERFERON INDUCED PROTEIN 3; PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGING; ALZHEIMER DISEASE; BASE SEQUENCE; CEREBRAL CORTEX; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 7044231566     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540412331286002     Document Type: Article

References (31)

1. Auld, D. S., Kornecook, T. J., Bastianetto, S., and Quirion, R. (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68, 209-245.
2. St George-Hyslop, P. H. (2000) Genetic factors in the genesis of Alzheimer's disease. Ann. NY Acad. Sci. 924, 1-7.
3. Poirier, J. (2000) Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann. NY Acad. Sci. 924, 81-90.
4. Holmes, C. (2002) Genotype and phenotype in Alzheimer's disease. Br. J. Psychiatry 180, 131-134.
5. Tanzi, R. E. and Bertram, L. (2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181-184.
6. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
7. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
8. Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., el al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38. 555-565.
9. Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., and Markesbery, W. R. (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103, 373-383.
10. Bickford, P. C., Gould, T., Briederick, L., Chadman, K., Pollock, A., Young, D., Shukitt-Hale, B., and Joseph, J. (2000) Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res. 866, 211-217.
11. Gibson, G. E. (2002) Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease. Free Radic. Biol. Med. 32, 1061-1070.
12. Casserly, I. and Topol, E. (2004) Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139-1146.
13. van Beek, J., Elward, K., and Gasque, P. (2003) Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. NY Acad. Sci. 992, 56-71.
14. Nixon, R. A., Mathews, P. M., and Cataldo. A. M. (2001) The neuronal endosomal-lysosomal system in Alzheimer's disease. J. Alzheimers Dis. 3, 97-107.
15. Forman, M. S., Lee, V. M., and Trojanowski, J. Q. (2003) 'Unfolding' pathways in neurodegenerative disease. Trends Neurosci. 26, 407-410.
16. Nixon, R. A., Saito, K. I., Grynspan, F., Griffin, W. R., Katayama, S., Honda, T., Mohan, P. S., Shea, T. B., and Beermann, M. (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747, 77-91.
17. Mattson, M. P., LaFerla, F. M., Chan, S. L., Leissring, M. A., Shepel, P. N., and Geiger, J. D. (2000) Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23, 222-229.
18. Petanceska, S. S., DeRosa, S., Olm, V., Diaz, N., Sharma, A., Thomas-Bryant, T., Duff, K., Pappolla, M., and Refolo, L. M. (2002) Statin therapy for Alzheimer's disease: will it work? J. Mol. Neurosci. 19, 155-161.
19. Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A., Berezovska, O., Hyman, B. T., Chang, T. Y., Tanzi, R. E., and Kovacs, D. M. (2001) Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat. Cell Biol. 3, 905-912.
20. Green, P. S. and Simpkins, J. W. (2000) Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann. NY Acad. Sci. 924, 93-98.
21. Mrak, R. E. and Griffin, W. S. (2001) Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 22, 903-908.
22. Hoffer, B., and Olson, L. (1997) Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques. J. Neural. Transm. Suppl. 49, 1-10.
23. Ginsberg, S. D., Hemby, S. E., Lee, V. M., Eberwine, J. H., and Trojanowski, J. Q. (2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neural. 48, 77-87.
24. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw, W. J. (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473.
25. Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., van Belle, G., and Berg, L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
26. Akhisaroglu, M., Manev, R., Akhisaroglu, E., Uz, T., and Manev, H. (2003) Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. Neuroreport 14, 1471-1473.
27. Mrak, R. E. and Griffinbc, W. S. (2001) The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 22, 915-922.
28. Li, Y., Wang, J., Sheng, J. G., Liu, L., Barger, S. W., Jones, R. A., Van Eldik, L. J., Mrak, R. E., and Griffin, W. S. (1998) S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71, 1421-1428.
29. Lewin, A. R., Reid, L. E., McMahon, M., Stark, G. R., and Kerr, I. M. (1991) Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199, 417-423.
30. Abbas, N., Bednar, I., Mix, E., Marie, S., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A., and Zhu, J. (2002) Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J. Neuroimmunol. 126, 50-57.
31. Tabaton, M. (2003) Mechanisms of soluble amyloid beta accumulation. Brain Pathology S1-S169.